Skip to main content
. 2018 Dec 21;38(6):BSR20180696. doi: 10.1042/BSR20180696

Figure 9. Down-regulated miR-182-5p inhibits cell cycle progression and cell apoptosis of osteoblasts.

Figure 9

(A) Cell cycle diagram depicting cell progression; (B) quantitative analysis for cell cycle progression in response to the treatment of miR-182-5p mimic, miR-182-5p inhibitor, si-ADCY6, miR-182-5p inhibitor + si-ADCY6, U0126 or miR-182-5p inhibitor + U0126; (C) flow cytometry map demonstrating cell apoptosis conditions; (D) apoptosis rate analysis for cells in response to the treatment of miR-182-5p mimic, miR-182-5p inhibitor, si-ADCY6, miR-182-5p inhibitor + si-ADCY6, U0126 or miR-182-5p inhibitor + U0126; *, P < 0.05 vs. the blank group and the NC group; #, P < 0.05 vs. the miR-182-5p inhibitor group; NC, negative control; miR-182-5p, microRNA-182-5p.